IAMOG
SGMO

Investors Asset Management of Georgia’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Investors Asset Management of Georgia’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,800
Closed -$9K – 452
2022
Q3 		$9K Hold
1,800
– – ﹤0.01% 487
2022
Q2 		$7K Buy
+1,800
New +$7.78K ﹤0.01% 450

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Investors Asset Management of Georgia's SGMO Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 1,800 shares — an estimated $9K sold.

Investors Asset Management of Georgia first reported a position in SGMO in Q2 2022 and held it in 2 quarters. The position peaked at $9K in Q3 2022. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • Investors Asset Management of Georgia reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 1,800 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $9K.
  • Investors Asset Management of Georgia first reported a position in SANGAMO THERAPEUTICS INC in Q2 2022 and held it in 2 quarters.
  • Investors Asset Management of Georgia's SANGAMO THERAPEUTICS INC position peaked at $9K in Q3 2022.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.